{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:23:10Z","timestamp":1777350190482,"version":"3.51.4"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA054851"],"award-info":[{"award-number":["R01DA054851"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA029910"],"award-info":[{"award-number":["R01DA029910"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.josat.2025.209682","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T08:34:41Z","timestamp":1742891681000},"page":"209682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring barriers and potential solutions before implementing a scale-up strategy to expand methadone coverage among people who inject drugs in Tajikistan"],"prefix":"10.1016","volume":"172","author":[{"given":"George L.","family":"O'Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn M.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abror","family":"Burkhonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gafur","family":"Mohsinzoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamoliddin","family":"Abdullozoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salomudin J.","family":"Yusufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209682_bb0005","series-title":"Opioid substitution therapy in selected countries of Eastern Europe and Central Asia","author":"Aizberg","year":"2008"},{"issue":"3","key":"10.1016\/j.josat.2025.209682_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Medicine"},{"issue":"10050","key":"10.1016\/j.josat.2025.209682_bb0015","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(16)30856-X","article-title":"The perfect storm: Incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia","volume":"388","author":"Altice","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.josat.2025.209682_bb0020","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S2215-0366(22)00318-2","article-title":"Collaborative learning and response to opioid misuse and HIV prevention in Ukraine during war","volume":"9","author":"Altice","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08897077.2018.1443541","article-title":"Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program","volume":"39","author":"Bachhuber","year":"2018","journal-title":"Substance Abuse"},{"issue":"12","key":"10.1016\/j.josat.2025.209682_bb0030","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/add.13055","article-title":"Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission","volume":"110","author":"Bachireddy","year":"2015","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.josat.2025.209682_bb0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/1524839920918551","article-title":"Formative research and cultural tailoring of a substance abuse prevention program for American Indian youth: Findings from the intertribal talking circle intervention","volume":"22","author":"Baldwin","year":"2021","journal-title":"Health Promotion Practice"},{"issue":"3","key":"10.1016\/j.josat.2025.209682_bb0040","first-page":"255","article-title":"\u201cBureaucracy & Beliefs\u201d: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine","volume":"22","author":"Bojko","year":"2015","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment","volume":"66","author":"Bojko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2025.209682_bb0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajhp\/zxad288","article-title":"Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings","volume":"81","author":"Bowman","year":"2023","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"10.1016\/j.josat.2025.209682_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135910457000100301","article-title":"Back-translation for cross-cultural research","volume":"1","author":"Brislin","year":"1970","journal-title":"Journal of Cross-Cultural Psychology"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26202","article-title":"Integrating methadone into primary care settings in Ukraine: Effects on provider stigma and knowledge","volume":"27","author":"Bromberg","year":"2023","journal-title":"Journal of the International AIDS Society"},{"key":"10.1016\/j.josat.2025.209682_bb0065","article-title":"Medications for opioid use disorder during war in Ukraine: Innovations in public and private clinic cooperation","volume":"20","author":"Bromberg","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.josat.2025.209682_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100583","article-title":"Medications for opioid use disorder during the war in Ukraine: A more comprehensive view on the government response\u2014Authors\u2019 reply","volume":"26","author":"Bromberg","year":"2023","journal-title":"The Lancet Regional Health\u2013Europe"},{"issue":"10","key":"10.1016\/j.josat.2025.209682_bb0075","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1007\/s10461-021-03359-w","article-title":"\u201cwho are you and what are you doing Here?\u201d: Social capital and barriers to movement along the HIV care cascade among Tajikistani migrants with HIV to Russia","volume":"25","author":"Bromberg","year":"2021","journal-title":"AIDS and Behavior"},{"issue":"5","key":"10.1016\/j.josat.2025.209682_bb0080","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/15248399231169791","article-title":"Improving HIV and HCV testing in substance use disorder programs (SUDs) that provide medications for opiate use disorder (MOUD): Role of addressing barriers and implementing universal and site-specific approaches","volume":"24","author":"Brooks","year":"2023","journal-title":"Health Promotion Practice"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0085","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: A national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Cmaj"},{"key":"10.1016\/j.josat.2025.209682_bb0090","series-title":"Improving cultural competence to reduce health disparities","article-title":"AHRQ comparative effectiveness reviews","author":"Butler","year":"2016"},{"issue":"10","key":"10.1016\/j.josat.2025.209682_bb0095","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s10461-015-1112-0","article-title":"Misclassification of men with reported HIV infection in Ukraine","volume":"19","author":"\u010cakalo","year":"2015","journal-title":"AIDS and Behavior"},{"issue":"12","key":"10.1016\/j.josat.2025.209682_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25647","article-title":"Pathways for reduction of HIV-related stigma: A model derived from longitudinal qualitative research in Kenya and Uganda","volume":"23","author":"Camlin","year":"2020","journal-title":"Journal of the International AIDS Society"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13722-017-0089-6","article-title":"Convenience without disclosure: A formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania","volume":"12","author":"Cooke","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"issue":"10208","key":"10.1016\/j.josat.2025.209682_bb0110","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action [systematic review]","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2025.209682_bb0115","series-title":"Group techniques for program planning--A guide to nominal group and delphi processes","author":"Delbecq","year":"1975"},{"issue":"5","key":"10.1016\/j.josat.2025.209682_bb0120","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/15248399231169928","article-title":"Challenges to achieving HCV Micro-elimination in people with HIV and recommended future implementation strategies by clinicians","volume":"24","author":"DiDomizio","year":"2023","journal-title":"Health Promotion Practice"},{"issue":"5","key":"10.1016\/j.josat.2025.209682_bb0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/15248399231169928","article-title":"Challenges to achieving HCV micro-elimination in people with HIV in the United States: Provider perspectives and the role of implicit bias","volume":"24","author":"DiDomizio","year":"2023","journal-title":"Health Promotion Practice"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0130","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1016\/S0168-8278(16)01503-8","article-title":"C-edge co-Star: Risk of reinfection following successful therapy with elbasvir and grazoprevir in persons who inject drugs (PWID) receiving opioid agonist therapy (OAT)","volume":"64","author":"Dore","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.josat.2025.209682_bb0135","first-page":"112a","article-title":"Hepatitis C virus (HCV) reinfection and injecting risk behavior following elbasvir (EBR)\/grazoprevir (GZR) treatment in participants on opiate agonist therapy (OAT): Co-STAR part B [conference abstract]","volume":"66","author":"Dore","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.josat.2025.209682_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108197","article-title":"Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic","volume":"121","author":"Dunn","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12954-022-00703-8","article-title":"Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder","volume":"19","author":"Eger","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"7565","key":"10.1016\/j.josat.2025.209682_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","article-title":"Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process","volume":"333","author":"Elwyn","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2025.209682_bb0155","series-title":"Measuring the sustainability of opioid agonist therapy (OAT)","author":"Eurasian Harm Reduction Association","year":"2019"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/15332700802127912","article-title":"Teaching the NIATx model of process improvement as an evidence-based process","volume":"6","author":"Evans","year":"2008","journal-title":"Journal of Teaching in the Addictions"},{"issue":"4","key":"10.1016\/j.josat.2025.209682_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1553-7250(08)34030-6","article-title":"A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice","volume":"34","author":"Feldstein","year":"2008","journal-title":"The Joint Commission Journal on Quality and Patient Safety"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12913-022-08948-6","article-title":"Opening the \u201cblack box\u201d of organizational coaching for implementation","volume":"23","author":"Fleddermann","year":"2023","journal-title":"BMC Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3241-4","article-title":"Using NIATx strategies to implement integrated services in routine care: A study protocol","volume":"18","author":"Ford","year":"2018","journal-title":"BMC Health Services Research"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.7326\/M21-4119","article-title":"Reinfection and risk behaviors after treatment of hepatitis C virus infection in persons receiving opioid agonist therapy\u202f: A cohort study","volume":"175","author":"Grebely","year":"2022","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2025.209682_bb0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2017.09.024","article-title":"Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment","volume":"181","author":"Haber","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209682_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111252","article-title":"Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center","volume":"257","author":"Haddad","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"issue":"1\u20132","key":"10.1016\/j.josat.2025.209682_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2012.12.008","article-title":"Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes","volume":"131","author":"Haddad","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11524-014-9924-1","article-title":"Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers [research Support, N.I.H., extramural]","volume":"92","author":"Haddad","year":"2015","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.josat.2025.209682_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108856","article-title":"Culturally adapted evidence-based treatments for adults with substance use problems: A systematic review and meta-analysis","volume":"226","author":"Hai","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209682_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpopen.2023.100111","article-title":"Governing health service purchasing agencies: Comparative study of national purchasing agencies in 10 countries in eastern Europe and central Asia","volume":"5","author":"Hawkins","year":"2023","journal-title":"Health Policy Open"},{"issue":"1\u20132","key":"10.1016\/j.josat.2025.209682_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2008.04.016","article-title":"Replication and sustainability of improved access and retention within the network for the improvement of addiction treatment","volume":"98","author":"Hoffman","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209682_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/ACM.0000000000001812","article-title":"The use of the Delphi and other consensus group methods in medical education research: A review","author":"Humphrey-Murto","year":"2017","journal-title":"Academic Medicine"},{"key":"10.1016\/j.josat.2025.209682_bb0225","series-title":"Improvement of treatment of drug use disorders in Central Asia the contribution of the EU Central Asia Drug Action Programme (CADAP)","author":"Ii","year":"2017"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0230","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/add.16565","article-title":"The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine","volume":"119","author":"Ivasiy","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209682_bb0235","article-title":"Responding to health policy recommendations on managing opioid use disorder during Russia\u2019s invasion of Ukraine: Divergent responses from the frontline to the west","volume":"10","author":"Ivasiy","year":"2022","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2025.209682_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100075","article-title":"Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years","volume":"4","author":"Ivasiy","year":"2022","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0245","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/add.16565","article-title":"The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine","volume":"119","author":"Ivasiy","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209682_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000934","article-title":"Low-threshold buprenorphine treatment in a syringe services program: Program description and outcomes","author":"Jakubowski","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209682_bb0255","series-title":"Tajikistan: Country fact sheet 2022","author":"Joint United Nations Program on HIV\/AIDS (UNAIDS)","year":"2022"},{"key":"10.1016\/j.josat.2025.209682_bb0260","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)"},{"issue":"7001","key":"10.1016\/j.josat.2025.209682_bb0265","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"Bmj"},{"key":"10.1016\/j.josat.2025.209682_bb0270","series-title":"Laboratory of socialist development: Cold War politics and decolonization in Soviet Tajikistan","author":"Kalinovsky","year":"2018"},{"issue":"4","key":"10.1016\/j.josat.2025.209682_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.21101\/cejph.a3562","article-title":"Select barriers to harm-reduction services for IDUs in Eastern Europe [journal article]","volume":"17","author":"Kehler Curth","year":"2009","journal-title":"Central European Journal of Public Health"},{"key":"10.1016\/j.josat.2025.209682_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugpo.2017.01.015","article-title":"The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective","volume":"43","author":"Klingemann","year":"2017","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104540","article-title":"Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers","volume":"130","author":"Kronfli","year":"2024","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104549","article-title":"Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake","volume":"131","author":"Lafferty","year":"2024","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104549","article-title":"Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake","volume":"131","author":"Lafferty","year":"2024","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13011-022-00483-1","article-title":"Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs","volume":"17","author":"Lambdin","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"7","key":"10.1016\/j.josat.2025.209682_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11920-019-1038-8","article-title":"HIV, drug injection, and harm reduction trends in Eastern Europe and Central Asia: Implications for international and domestic policy","volume":"21","author":"LaMonaca","year":"2019","journal-title":"Current Psychiatry Reports"},{"issue":"12","key":"10.1016\/j.josat.2025.209682_bb0310","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/liv.14152","article-title":"Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs [Meta-Analysis Research Support, Non-U.S. Gov\u2019t Systematic Review]","volume":"39","author":"Latham","year":"2019","journal-title":"Liver International"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7517-8-32","article-title":"The Soviet doctor and the treatment of drug addiction: \u201cA difficult and most ungracious task\u201d [journal article]","volume":"8","author":"Latypov","year":"2011","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.31389\/jied.208","article-title":"Stalled scale-up of opioid agonist therapies for HIV prevention in Kazakhstan: History, policy, and recommendations for change","volume":"5","author":"Liberman","year":"2024","journal-title":"Journal of Illicit Economies and Development"},{"key":"10.1016\/j.josat.2025.209682_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103209","article-title":"Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information [Research Support, N.I.H., Extramural]","volume":"94","author":"Liberman","year":"2021","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2025.209682_bb0330","article-title":"Trajectory and progress of opioid agonist therapy programs in the Kyrgyz Republic","volume":"2","author":"Liberman","year":"2024","journal-title":"Global Health Economics and Sustainability"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review","volume":"107","author":"Livingston","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209682_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104682","article-title":"Provider attitudes associated with improved quality health indicators of people who inject drugs prescribed methadone maintenance in primary healthcare settings in Ukraine","volume":"136","author":"Machavariani","year":"2025","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104682","article-title":"Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine","volume":"136","author":"Machavariani","year":"2025","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107690","article-title":"Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine","volume":"146","author":"Machiavariani","year":"2024","journal-title":"Contemporary Clinical Trials"},{"issue":"Suppl. 3","key":"10.1016\/j.josat.2025.209682_bb0355","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: A rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209682_bb0360","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2025.209682_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugpo.2017.07.025","article-title":"Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine","volume":"49","author":"Madden","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.josat.2025.209682_bb0370","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/add.14198","article-title":"An investigation of an open-access model for scaling up methadone maintenance treatment","volume":"113","author":"Madden","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209682_bb0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugpo.2017.05.037","article-title":"Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine [Research Support, N.I.H., Extramural]","volume":"45","author":"Makarenko","year":"2017","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209682_bb0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2016.06.011","article-title":"Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","volume":"165","author":"Makarenko","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0385","first-page":"163","article-title":"In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine","volume":"23","author":"Mazhnaya","year":"2016","journal-title":"Drugs (Abingdon Engl)"},{"key":"10.1016\/j.josat.2025.209682_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1238188","article-title":"Qualitative exploration of early experiences of opioid use disorder patients from private clinics after Russia\u2019s invasion of Ukraine in six large cities in Ukraine","volume":"11","author":"Mazhnaya","year":"2023","journal-title":"Frontiers in Public Health"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0395","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1176\/appi.ajp.2021.20101548","article-title":"Office-based methadone treatment for opioid use disorder and pharmacy dispensing: A scoping review","volume":"178","author":"McCarty","year":"2021","journal-title":"American Journal of Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.josat.2025.209682_bb0400","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugalcdep.2006.10.009","article-title":"The network for the improvement of addiction treatment (NIATx): Enhancing access and retention","volume":"88","author":"McCarty","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209682_bb0405","series-title":"Simply psychology","article-title":"Reliability in psychology research: Definitions & examples","author":"Mcleod","year":"2023"},{"key":"10.1016\/j.josat.2025.209682_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108164","article-title":"Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine [Research Support, N.I.H., Extramural]","volume":"121","author":"Meteliuk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0415","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12955-020-01599-3","article-title":"The effect of methadone on depression among addicts: A systematic review and meta-analysis","volume":"18","author":"Mohammadi","year":"2020","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"10.1016\/j.josat.2025.209682_bb0420","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/add.14797","article-title":"Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: Dynamic modeling analysis [Research Support, N.I.H., Extramural]","volume":"115","author":"Morozova","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209682_bb0425","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2016.12.025","article-title":"Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine [Comparative Study Observational Study]","volume":"173","author":"Morozova","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2025.209682_bb0430","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.drugpo.2014.03.007","article-title":"Mortality of registered drug users in Central Asia","volume":"25","author":"Mravcik","year":"2014","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2025.209682_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.josat.2025.209682_bb0440","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","volume":"100","author":"Muthulingam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209682_bb0445","article-title":"Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis","volume":"154","author":"Muthulingam","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0450","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2352-3018(23)00150-9","article-title":"Global HIV control: Is the glass half empty or half full?","volume":"10","author":"Nachega","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.josat.2025.209682_bb0455","article-title":"Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study [research Support, N.I.H., extramural]","volume":"136","author":"O\u2019Hara","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1016\/j.josat.2025.209682_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000344","article-title":"Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial","volume":"2","author":"Pashchenko","year":"2022","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.josat.2025.209682_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2014.12.008","article-title":"Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV\/AIDS [research Support, N.I.H., extramural]","volume":"148","author":"Polonsky","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2025.209682_bb0470","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: Incarceration effects and exploration of mediators","volume":"20","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0475","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijerph19010022","article-title":"Educating young adults about opioid misuse: Evidence from a mass media intervention","volume":"19","author":"Rath","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.josat.2025.209682_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpopen.2023.100110","article-title":"Primary care reforms in Central Asia \u2013 On the path to universal health coverage?","volume":"5","author":"Rechel","year":"2023","journal-title":"Health Policy Open"},{"key":"10.1016\/j.josat.2025.209682_bb0485","series-title":"Clinical management using replacement therapy in opioid dependence in narcological institutions of the Republic of Tajikistan","author":"Republic of Tajikistan Ministry of Health","year":"2015"},{"key":"10.1016\/j.josat.2025.209682_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-015-0037-2","article-title":"Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: The case of Sweden","volume":"12","author":"Richert","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"10.1016\/j.josat.2025.209682_bb0495","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3390\/ijerph20095669","article-title":"Barriers and facilitators to pre-exposure prophylaxis by men who have sex with men and community stakeholders in Malaysia","volume":"20","author":"Rosen","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"13","key":"10.1016\/j.josat.2025.209682_bb0500","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1177\/1049732317732307","article-title":"Why people who inject drugs voluntarily transition off methadone in Ukraine [multicenter study]","volume":"27","author":"Rozanova","year":"2017","journal-title":"Qualitative Health Research"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0505","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/1471-2458-10-447","article-title":"Public health triangulation: Approach and application to synthesizing data to understand national and local HIV epidemics","volume":"10","author":"Rutherford","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.josat.2025.209682_bb0510","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12913-015-1215-3","article-title":"The ideal healthcare: Priorities of people with chronic conditions and their carers","volume":"15","author":"Sav","year":"2015","journal-title":"BMC Health Services Research"},{"issue":"5","key":"10.1016\/j.josat.2025.209682_bb0515","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.pec.2018.12.020","article-title":"The impact and utility of encounter patient decision aids: Systematic review, meta-analysis and narrative synthesis","volume":"102","author":"Scalia","year":"2019","journal-title":"Patient Education and Counseling"},{"issue":"4","key":"10.1016\/j.josat.2025.209682_bb0520","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jsat.2012.03.008","article-title":"Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence","volume":"43","author":"Schwarz","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209682_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103570","article-title":"Treatment of hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients","volume":"101","author":"Sivakumar","year":"2022","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0530","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10550887.2010.531670","article-title":"Opiate-addicted parents in methadone treatment: Long-term recovery, health, and family relationships","volume":"30","author":"Skinner","year":"2011","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2025.209682_bb0535","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.josat.2025.209682_bb0540","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2215-0366(20)30538-1","article-title":"Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: A three-setting analysis [research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]","volume":"8","author":"Stone","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.josat.2025.209682_bb0545","article-title":"Evaluating the impact and cost-effectiveness of scaling-up HCV treatment among people who inject drugs in Ukraine [preprint]","volume":"14","author":"Stone","year":"2021","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0550","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12954-024-01050-6","article-title":"Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020\u20132023","volume":"21","author":"Stuikyte","year":"2024","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0555","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S2352-3018(19)30373-X","article-title":"Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: A modelling study","volume":"7","author":"Tan","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.josat.2025.209682_bb0560","author":"The World Bank"},{"issue":"6","key":"10.1016\/j.josat.2025.209682_bb0565","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.30965\/22142290-bja10014","article-title":"Uchyot and Foucault: Drug users and migrants in post-soviet Central Asia and Russia","volume":"8","author":"Turaeva","year":"2021","journal-title":"Central Asian Affairs"},{"key":"10.1016\/j.josat.2025.209682_bb0575","author":"United Nations Office on Drugs and Crime"},{"key":"10.1016\/j.josat.2025.209682_bb0580","author":"United Nations Office on Drugs and Crime"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2025.209682_bb0585","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.drugalcdep.2013.07.010","article-title":"A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment","volume":"132","author":"Vagenas","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"22","key":"10.1016\/j.josat.2025.209682_bb0590","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0595","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1078345814557513","article-title":"Validation of a brief measure of opioid dependence: The rapid opioid dependence screen (RODS)","volume":"21","author":"Wickersham","year":"2015","journal-title":"Journal of Correctional Health Care"},{"issue":"2","key":"10.1016\/j.josat.2025.209682_bb0600","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2471\/BLT.12.109132","article-title":"Implementing methadone maintenance treatment in prisons in Malaysia [research Support, N.I.H., extramural research Support, non-U.S. Gov\u2019t]","volume":"91","author":"Wickersham","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.josat.2025.209682_bb0605","article-title":"\u201cDon\u2019t judge a book its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma","volume":"11","author":"Woo","year":"2017","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2025.209682_bb0610","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.josat.2025.209682_bb0615","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12954-022-00692-8","article-title":"Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: A qualitative study","volume":"19","author":"Yee","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1016\/j.josat.2025.209682_bb0620","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/ciaa142","article-title":"Modeling combination hepatitis C virus treatment and prevention strategies in a network of people who inject drugs in the United States [research support, N.I.H., extramural research support, non-U.S. Gov\u2019t]","volume":"72","author":"Zelenev","year":"2021","journal-title":"Clinical Infectious Diseases"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:49:01Z","timestamp":1745030941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294987592500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":124,"alternative-id":["S294987592500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209682","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring barriers and potential solutions before implementing a scale-up strategy to expand methadone coverage among people who inject drugs in Tajikistan","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209682"}}